Craig C. Hopkinson - Feb 18, 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Role
EVP R&D, Chief Medical Officer
Signature
/s/ Jeffrey Geary, attorney-in-fact for Craig C. Hopkinson
Stock symbol
ALKS
Transactions as of
Feb 18, 2024
Transactions value $
-$266,086
Form type
4
Date filed
2/21/2024, 05:32 PM
Previous filing
Feb 12, 2024
Next filing
Feb 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALKS Ordinary Shares Options Exercise +8.9K +10.12% 96.8K Feb 18, 2024 Direct F1
transaction ALKS Ordinary Shares Tax liability -$127K -3.95K -4.08% $32.18 92.9K Feb 18, 2024 Direct
transaction ALKS Ordinary Shares Options Exercise +10.3K +11.09% 103K Feb 20, 2024 Direct F1
transaction ALKS Ordinary Shares Tax liability -$139K -4.57K -4.43% $30.39 98.6K Feb 20, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALKS Restricted Stock Unit Award Options Exercise -8.9K -33.33% 17.8K Feb 18, 2024 Ordinary Shares 8.9K Direct F1, F2
transaction ALKS Restricted Stock Unit Award Options Exercise -10.3K -100% 0 Feb 20, 2024 Ordinary Shares 10.3K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one ordinary share.
F2 Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023.
F3 Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/20/2021.